Sort   by:  
 Page size 
UnknownGenome-wide characterization of the MBF1 gene family and its expression pattern in different tissues and stresses in Zanthoxylum armatum.
Not available
S-EPMC9472409 | biostudies-literature
UnknownThe mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis.
Not available
S-EPMC2929599 | biostudies-literature
UnknownImmunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis.
Not available
S-EPMC9782384 | biostudies-literature
MetabolomicsPu-erh tea and theabrownin ameliorate metabolic syndrome in mice via potential microbiota-gut-liver-brain interactions
Metabolic syndrome (MS) is a common metabolic disorder characterized by obesity, insulin resistance, cardiovascular disease and gut microbiota dysbiosis. Pu-erh tea and its ingredient theabrownin have known functions on the reduction of body weight gain and fat accumulation. However, few studies sys...
2024-09-25 | MTBLS2594 | MetaboLights
UnknownPreliminary assessment of the therapeutic potential of staphylococcal enterotoxin-like W via biological activity and TCR binding sites analysis.
Not available
S-EPMC12407819 | biostudies-literature
UnknownThermal migration towards constructing W-W dual-sites for boosted alkaline hydrogen evolution reaction.
Not available
S-EPMC8828749 | biostudies-literature
UnknownAssociation between Polymorphisms in IL-16 Genes and Coronary Heart Disease risk.
Not available
S-EPMC3817778 | biostudies-literature
MetabolomicsAirway Dysbiosis Accelerates Lung Function Decline in Chronic Obstructive Pulmonary Disease (Human UPLC-MS/MS assays)

Progressive decline in lung function is a hallmark of chronic obstructive pulmonary disease (COPD). Although airway dysbiosis occurs in COPD, whether it contributes to disease progression remains unknown. Here, through a longitudinal analysis on 181 COPD individuals from two large cohorts involvi...

2023-06-12 | MTBLS5423 | MetaboLights
UnknownPurification and in situ immobilization of papain with aqueous two-phase system.
Not available
S-EPMC3001450 | biostudies-literature
ProteomicsMZH29 is a novel potent FLT3 tyrosine kinase inhibitor with activity of overcoming drug resistant mutations in AML
In this study, we screened a group of newly synthesized tyrosine kinase inhibitors, and discovered MZH29 was a potent FLT3 inhibitor. Remarkably, MZH29 is well tolerated and effective in the clinically known FLT3 mutants in the constructed BaF3 model cells. MZH29 could also lead to complete tumor re...
ORGANISM(S): Homo sapiens (Human) Apis mellifera (Honeybee) 
2016-12-12 | PXD004278 | Pride
Tyrosine kinases inhibitor  aml  drug resistance  mv4-11 
Sort   by:  
 Page size